News | October 05, 2010

Study Shows Telemedicine Can Identify Heart Problems in Children

October 5, 2010 – Rapid electronic review of children’s heart images by remote specialists can allow for earlier diagnosis and treatment of potentially serious pediatric heart problems. A new study by researchers from Children’s Mercy Hospitals and Clinics found that telemedicine can help children who are far from a specialized medical center.

The study was presented at the American Academy of Pediatrics National Conference and Exhibition in San Francisco.

Researchers looked at 11 years of data on first-time pediatric echocardiograms performed at St. John's Medical Center in Joplin, Mo., and transmitted to pediatric heart specialists at Children's Mercy 160 miles away, between April 1998 and October 2009.

More than 70 percent of the echocardiograms were ordered due to the local physician hearing a heart murmur. Nearly three-quarters were determined by Children's Mercy specialists to be normal.

Of the 905 echocardiograms evaluated, only 15 (1.7 percent) resulted in a transfer to Children's Mercy for treatment.

"Satellite heart imaging labs like the one evaluated in this study can give parents fast access to pediatric expertise they might not otherwise have, and that can often be reassuring," said Seiji Ito, M.D., resident at Children's Mercy Hospitals and Clinics, and co-author of the study. "This study helps illustrate how telemedicine can save families significant worry, time and expense. It alleviates the need to make appointments with an unfamiliar doctor in a city far away, and endure a lengthy road trip that ultimately could prove to be unnecessary."

Telemedicine involves the use communication technology to share health information among physicians or between physicians and patients. During the study, the method of transmission evolved from videotape over integrated services digital network (ISDN), to digital studies transmitted over the internet.

For more information: www.childrens-mercy.org


Related Content

News | Cardiovascular Clinical Studies

Nov. 10, 2025 —Genomics, a science-led techbio company, has today announced new research that suggests polygenic risk ...

Home November 12, 2025
Home
News | Cardiovascular Clinical Studies

Oct. 21, 2025 – AskBio Inc., a gene therapy company wholly owned and independently operated as a subsidiary of Bayer AG ...

Home October 21, 2025
Home
News | Cardiovascular Clinical Studies

Aug. 25, 2025 — Merck, known as MSD outside of the United States and Canada, has announced that new clinical trial and ...

Home August 25, 2025
Home
News | Cardiovascular Clinical Studies

Aug. 18, 2025 — (Newswise) It’s often mistaken for a heart attack, but Takotsubo cardiomyopathy — previously known as ...

Home August 21, 2025
Home
News | Cardiovascular Clinical Studies

Aug. 20, 2025 — A major international study published in Atherosclerosis* has found that routinely testing for ...

Home August 20, 2025
Home
News | Cardiovascular Clinical Studies

Aug. 4, 2025 — Marea Therapeutics, Inc., a clinical-stage biotechnology company that develops next-generation medicines ...

Home August 04, 2025
Home
News | Cardiovascular Clinical Studies

July 16, 2025 — Medtronic has announced that the first patient has been enrolled in the PEripheral Onyx Liquid Embolic ...

Home July 22, 2025
Home
News | Cardiovascular Clinical Studies

June 11, 2025 — Bayer and the Broad Institute have have extended their research collaboration of 10 years by an ...

Home June 11, 2025
Home
News | Cardiovascular Clinical Studies

May 27, 2025 — Despite scientific advances in cardiovascular care, people in living in rural areas and other communities ...

Home May 27, 2025
Home
News | Cardiovascular Clinical Studies

May 20, 2025 — Shockwave Medical, Inc., part of Johnson & Johnson MedTechhas announced the 30-day primary endpoint ...

Home May 21, 2025
Home
Subscribe Now